Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1114 of 5804
-
New pill takes on advanced cancers in early human trial
Disease control Not yet recruitingThis study is an open-label, dose-escalation, multicenter Phase I/II study conducted in patients with advanced solid tumors. The target population for this study consists of patients with advanced solid tumors who have failed or are intolerant to standard treatments. The study is…
Phase: PHASE1, PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New study aims to stop postpartum bleeding in At-Risk moms
Prevention Not yet recruitingPostpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality worldwide, particularly among women with known risk factors. Uterotonic agents are routinely administered after vaginal delivery to prevent excessive bleeding. Carbetocin, a long-acting oxytocin an…
Phase: NA • Sponsor: Western Galilee Hospital-Nahariya • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
New hope for stomach cancer: immunotherapy combo targets resistant tumors
Disease control Not yet recruitingdMMR/MSI-H is a key molecular subtype of gastric cancer, found in 8-22% of cases. It is typically associated with older age, female sex, distal tumor location, and intestinal histology (Lauren classification). While this subtype predicts better survival in locally advanced diseas…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a single chemo drug replace the standard doublet for some ovarian cancers?
Disease control Not yet recruitingPlatinum-based neoadjuvant chemotherapy (NACT) followed by interval debulking surgery is a crucial treatment paradigm for advanced ovarian cancer. It can reduce tumor burden, increase the rate of R0 resection, and decrease surgical complications. The combination of paclitaxel and…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Weekly shot may beat daily shots for blood recovery after transplant
Disease control Recruiting nowThis study is for adults aged 18-65 with myelodysplastic syndrome (MDS) or severe aplastic anemia (AA) who are scheduled to receive a donor stem cell transplant (allogeneic hematopoietic stem cell transplant). After the transplant, it is critical for the body to start making its …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Engineered macrophages take on Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single-arm, open-label, single-center, dose-escalation platform clinical trial design. Using an adenovirus vector platform, the study aims to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary anti-tumor activity of investigational CAR-M…
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can pressurized oxygen soothe chemo nerve pain?
Symptom relief Not yet recruitingThe goal of this research is to assess whether hyperbaric oxygen therapy can alleviate the symptoms of Nab-paclitaxel-induced peripheral neuropathy and improve patient-reported quality of life.
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New rabies shot could shield millions after bites
Prevention Not yet recruitingA Phase II, Single-Center, Randomized, Blinded, Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody Injection in Healthy Subjects
Phase: PHASE2 • Sponsor: Lanzhou Institute of Biological Products Co., Ltd • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Recruiting nowThis study is a prospective, single-arm, single-center trial evaluating the efficacy of TACE combined with multimodal ablation, Tislelizumab, and lenvatinib in the treatment of unresectable primary liver cancer.
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Brain pacemaker gets smarter to stop freezing in Parkinson's
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if adaptive deep brain stimulation (DBS) can decrease or prevent freezing of gait in participants with Parkinson's disease.
Phase: NA • Sponsor: Doris Wang, MD, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Keto diet may supercharge cancer immunotherapy, early trial hints
Disease control Recruiting nowThis study investigates whether raising blood levels of beta-hydroxybutyrate (BHB) - a natural molecule produced by the body during fasting or a low-carbohydrate diet - is safe and feasible and can improve the effectiveness of immunotherapy in patients with multiple myeloma, whil…
Phase: NA • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Budget air purifiers may slash asthma attacks in city kids
Disease control Recruiting nowThis project will investigate the effectiveness of HEPA air cleaners in reducing indoor air pollution and improving asthma morbidity in children living in East Harlem, New York City (NYC). The study will be conducted over a 2-year period. Columbia University and Little Sisters o…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for kids with rare calcium disease: encaleret trial launches
Disease control Recruiting nowThe overall objective of this study is to evaluate the pharmacokinetics (PK), efficacy, and safety of encaleret in pediatric participants from birth to 17 years of age with ADH1.
Phase: PHASE2, PHASE3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New gel could ease pain and heal wounds for kids with butterfly skin
Symptom relief Recruiting nowThis is a Phase 2, double-blind, randomized, vehicle-controlled study designed to evaluate efficacy, safety, and tolerability of topically applied TCP-25 gel in patients with confirmed DEB or JEB. The study will implement intrasubject randomization, ie, a pair of matching index w…
Phase: PHASE2 • Sponsor: Xinnate AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New combo tackles breast cancer in the liver
Disease control Recruiting nowThis phase II trial tests how well cemiplimab and transarterial radioembolization (TARE) with yttrium-90 (Y90) SIR-Spheres, registered trademark, works in treating breast cancer that has spread from where it first started (primary site) to the liver (metastatic). Immunotherapy wi…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could keeping patients breathing naturally during lung transplant speed recovery?
Disease control Not yet recruitingThe goal of this prospective, multicenter, single-arm clinical study is to learn whether a breathing-preserved anesthesia-surgical strategy can improve early recovery and perioperative survival in adults undergoing rescue/bridge lung transplantation. The main questions it aims t…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New lung transplant method lets patients breathe naturally during surgery
Disease control Not yet recruitingThe goal of this prospective, multicenter, single-arm cohort study is to learn whether a lung transplantation approach that preserves patients' spontaneous breathing during surgery can improve early recovery in adults aged 70 years and older undergoing allogeneic lung transplanta…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Experimental cell therapy takes on deadliest brain cancer
Disease control Not yet recruitingThis is an open-Label, dose-escalation, multiple administration, exploratory clinical study to evaluate the safety, tolerability, and anti-tumor activity of TH-CART-027 cell injection in subjects with recurrent or progressive grade 4 glioma
Phase: EARLY_PHASE1 • Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Shocking tinnitus away: new brain retraining trial offers hope
Symptom relief Recruiting nowThis study tests whether pairing non-invasive stimulation of the greater occipital nerve (NITESGON) with an attentionally demanding auditory frequency discrimination training task reduces tinnitus loudness and tinnitus-related distress. One hundred adults with chronic tonal tinni…
Phase: NA • Sponsor: University of Dublin, Trinity College • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control Recruiting nowThis study will investigate the safety and effectiveness of a new combination treatment for patients with advanced bile duct cancer. The treatment combines standard chemotherapy drugs (gemcitabine and cisplatin) with two additional medications: adebrelimab and simvastatin. All p…
Phase: PHASE1, PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC